Sponsored Content

How to Establish a Containment Strategy for Pharma Potent Compounds Manufacturing
Ana Fernandez Garcia
Telstar banner

The aim of this article is to help understand the main containment principles and to present the steps to be followed when establishing a containment strategy. It provides an overview of the “ISPE Good Practice Guide: Containment for Potent Compounds”, published in December 2022. The guide is a success of knowledge consolidation to create a common understanding, a brilliant description of the risk-based methodology and the technologies currently used in pharmaceutical industry.

About Telstar 

Telstar, part of Syntegon, is specialized in the development of GMP consultancy, engineering & construction projects and integrated process equipment, for companies associated with Life & Health Sciences (pharmaceutical & biotechnology, healthcare, cosmetic, veterinary and food & beverage industries, hospitals, laboratories & research centers). Acknowledged as one of the 10 major suppliers for the pharmaceutical industry, Telstar is one of the few international brands able to offer integrated process solutions for the biopharmaceutical industry with in-house sterilization, freeze drying, clean air and cold storage technologies.

Download Sponsored Content

To download this sponsored content, complete the form below. Once submitted, you will receive a link via the email you provided to download the sponsored content.

Company Type

By completing this form, you consent to have your information provided to the third-party sponsor of this content and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you . ISPE will store your information in a secure environment and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you. You may unsubscribe from these ISPE communications at any time. For more information or to unsubscribe, review our Privacy Policy or contact us at ask@ispe.org.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Facilities & Equipment Product Development
Containment Manufacturing Operations

About the Author

Ana Fernandez Garcia
Pharmaceutical Technology Manager
Syntegon Telstar Technologies
Ana Fernández García, Pharmaceutical Technology Manager at Telstar’s CRS Engineering, holds a MEng in Industrial Engineering from the UPM (Madrid, Spain) together with a MEng...